Problem
Restrictive practices in trade in pharmaceutical products
Other Names:
Restrictive drugs trade Incidence:
(2020 data) The stomach-acid drug Nexium, is manufactured in Sweden. One 40mg pill costs $7.78 in the USA compared to $3.37 in Canada. The price drops even more to $2.21 in the U.K., Australia and New Zealand. In India and Turkey, the same pill costs less than 37 cents. The antipsychotic drug Abilify is manufactured in Japan. The cost in the USA is $34.51 per pill. The same pill costs $4.65 in Canada - 87-percent less than in the U.S.
Fear of political and legal reprisals from the USA pharmaceutical industry has prevented the WHO from giving international approval to a new abortion pill, so inhibiting its world-wide marketing for family planning purposes.
Broader Problems:
Irresponsible pharmaceutical practicesUnderdevelopment of the pharmaceutical industryRestrictive practices in trade in manufactured goods Narrower Problems:
Embargo on medicinesRefusal to market new drugsExcessive restrictions to legalizing medicationsNon-responsiveness of transnational corporations to pharmaceutical needs Aggravates:
Restriction of abortionCriminalization of drug useInsufficient medical suppliesSecrecy about pharmaceutical productsConfusion among drugs with similar namesDistortion of international trade by discriminatory formulation of health and sanitary regulations for agricultural and pharmaceutical products Values:
NonrestrictiveRestriction Subject(s):
Commerce → TradeHealth Care → Pharmacy
Industry → Products
Societal Problems → Restrictions
Related UN Sustainable Development Goals:
Problem Type:
E: Emanations of other problems Date of last update
31.01.2020 – 08:51 CET